- Home
- ORIS vs OGEN Comparison
ORIS vs OGEN Comparison
Compare ORIS & OGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ORIS
- OGEN
- Stock Information
- Founded
- ORIS 2014
- OGEN 1996
- Country
- ORIS China
- OGEN United States
- Employees
- ORIS N/A
- OGEN N/A
- Industry
- ORIS Farming/Seeds/Milling
- OGEN Biotechnology: Pharmaceutical Preparations
- Sector
- ORIS Consumer Staples
- OGEN Health Care
- Exchange
- ORIS Nasdaq
- OGEN Nasdaq
- Market Cap
- ORIS 5.3M
- OGEN 5.4M
- IPO Year
- ORIS 2024
- OGEN N/A
- Fundamental
- Price
- ORIS $0.16
- OGEN $1.30
- Analyst Decision
- ORIS
- OGEN
- Analyst Count
- ORIS 0
- OGEN 0
- Target Price
- ORIS N/A
- OGEN N/A
- AVG Volume (30 Days)
- ORIS 37.8M
- OGEN 247.6K
- Earning Date
- ORIS 01-01-0001
- OGEN 11-12-2025
- Dividend Yield
- ORIS N/A
- OGEN N/A
- EPS Growth
- ORIS N/A
- OGEN N/A
- EPS
- ORIS 0.17
- OGEN N/A
- Revenue
- ORIS $15,014,000.00
- OGEN N/A
- Revenue This Year
- ORIS N/A
- OGEN N/A
- Revenue Next Year
- ORIS N/A
- OGEN N/A
- P/E Ratio
- ORIS $0.98
- OGEN N/A
- Revenue Growth
- ORIS N/A
- OGEN N/A
- 52 Week Low
- ORIS $0.08
- OGEN $1.01
- 52 Week High
- ORIS $56.01
- OGEN $18.90
- Technical
- Relative Strength Index (RSI)
- ORIS 46.18
- OGEN 49.55
- Support Level
- ORIS $0.14
- OGEN $1.27
- Resistance Level
- ORIS $0.17
- OGEN $1.45
- Average True Range (ATR)
- ORIS 0.03
- OGEN 0.08
- MACD
- ORIS -0.00
- OGEN -0.00
- Stochastic Oscillator
- ORIS 12.60
- OGEN 21.05
About ORIS Oriental Rise Holdings Limited Ordinary Shares
Oriental Rise Holdings Ltd is an integrated supplier of tea products in China. It is principally engaged in the business of planting, cultivating, processing, and selling processed tea. The company currently produces and sells three categories of products: roughly processed white tea, roughly processed black tea, and refined tea. The company's business operations are vertically integrated, covering cultivation, processing of tea leaves, and the sale of tea products to tea business operators and end-user retail customers. Geographically, the company generates all of its revenue from its business in the People's Republic of China (the PRC).
About OGEN Oragenics Inc.
Oragenics Inc is engaged in the research and development of nasal delivery pharmaceutical medications in neurology and fighting infectious diseases. The company's product ONP-002 is a fully synthetic, non-naturally occurring neurosteroid, is lipophilic, and can cross the blood-brain barrier to rapidly reduce swelling, oxidative stress and inflammation while restoring proper blood flow through gene amplification. The Company operates in one reportable segment, which includes activities related to advancing the development of its concussion drug, ONP-002.